Increased opportunities for better patient outcomes

The LUCAS device has shown to transform resuscitation by allowing for prolonged efforts
with good circulation, bringing time back on your side, extending the reach of care and bridging to PCI/ECMO.

RANDOMIZED CONTROLLED TRIALS

Proven safe and effective in highest level of evidence

The highest level of evidence, randomized, controlled LINC1 (LUCAS in Cardiac Arrest) trial on 2,589 pre-hospital cardiac arrest patients shows:

  • LUCAS is safe and effective
  • Very good neurological outcomes

Another randomized, controlled trial on 259 cardiac arrest patients has shown:

  • LUCAS did not cause more injuries than manual CPR2

Read more in LINC summary
Koster Clinical Summary 
US versions - for Intl. English version, see Resources

>99%

of the survivors treated with LUCAS had
a good neurological outcome at 6 months follow up1

Studied more than any other mechanical CPR device

There are over 200 publications on LUCAS, ranging from clinical studies,patient series, ECMO, PCI, manikin, experimental and organ donation studies.

DOWNLOAD

LUCAS selected bibliography or LUCAS selected bibliography summaries

US versions - for Intl. English version, see Resources
OUTCOME DATA

A helpful tool for progressive systems of care

Systems of care implementing LUCAS together with a comprehensive approach to resuscitation have shown increased ROSC rates3, 4, 5, 6, 7, 8, 9, 24, 25 as well as improved survival with good neurological outcomes5, 7, 10, 25 compared to historical data.

The Emergency Department at North Shore University Hospital, NY, US, significantly improved their ROSC rates, going from 26 % to 41%, using LUCAS chest compressions, a team-focused resuscitation strategy and video-reviews. Read more how they managed to improve their ROSC rates significantly.

Pre-hospital sudden cardiac arrest patients

In-hospital sudden cardiac arrest patients

BLOOD CIRCULATION

More flow to the brain and heart with the LUCAS device

Increased flow to the brain

LUCAS has shown to create more blood flow to the brain both in humans and experimental studies compared to manual CPR.11, 12

Sustain coronary perfusion pressures

LUCAS chest compressions have shown sustain coronary perfusion pressures over the 15mmHg threshold, as well as coronary artery blood flow (TIMI III)13, 14

21%

increase of mean average ETCO2 value comparedto manual CPR15

QUALITY CPR

High-quality CPR with less interruptions

Delivery of high-quality CPR is vital for patient outcomes.

The LUCAS device delivers safe and effective chest compressions with Guidelines-consistent depth of 5.3 cm / 2.1 inches and rate of 102 per minute*

* LUCAS 3, version 3.1 can be configured for depth and rate

LUCAS allows for defibrillation during ongoing compressions

LUCAS allows for application of the defibrillation electrodes outside the suction cup. The LUCAS device does not need to be stopped when delivering the shock (only stop when doing the rhythm analysis).1


DOWNLOAD

Defibrillation and ventilation with LUCAS

US version - for Intl. English version, see Resources

More CPR time with LUCAS

LUCAS has documented chest compression fractions of up to 93%, leading  to significantly more flow time compared to manual CPR.16, 17, 18, 19, 20

Bridge to definitive care 

Some cardiac arrest patients will not respond to CPR and defibrillation alone.

LUCAS allows for lifesaving interventions (such as PCI and ECMO/ECPR) by providing consistent compressions on the way to and during these advanced life-saving therapies. 

Facilitates cardio-cerebralperfusion during prolonged CPR

Numerous documented saves with good neurological outcomes after consistent, high-quality LUCAS compressions for 1, 2, 3, 4+ hours. 

Buys time to find and treat reversible causes

From 8.2% historical survival to 50% survival with good neurological function implementing a progressive approach to take appropriate patients from the field to the hospital for advanced life-saving interventions, such as ECMO and PCI.21


LUCAS buys time and allows for the simultaneous diagnosis and treatment of reversible causes, e.g. coronary occlusion, pulmonary emboli, intoxication or accidental hypothermia.

Saves lives in the cath lab

  • Using LUCAS during a continued coronary intervention, 25% vs. historical 10% of sudden cardiac arrest patients who did not respond to normal advanced resuscitation efforts, could be saved with good neurological outcome.22 This despite prolonged CPR durations of up to 50 minutes. 


  • Life-saving PCI during LUCAS chest compressions leads to significant improvements in ROSC in cardiac arrest patients with persistent VF or non-shockable rhythms.23

Take the next step

Want to talk to your sales representative? Please fill out the form on stryker.com and we’ll connect you with your local Stryker Account Manager